ACTGNetwork

AIDS Clinical Trials Group (ACTG) Network investigators share why they chose careers in HIV research.

Want to learn about the latest HIV research being conducted by ACTG researchers? Watch this video featuring investigators from one of our Boston site's discussing what they are currently working on in the lab!

Chronic non-communicable illnesses like diabetes and heart disease kill people living with HIV, not the virus itself, researchers say. They suggest regular screening for chronic diseases and management of risk factors to prevent negative health outcomes. #hiv #aids #health #research #science http://ift.tt/1z8CHHM

Chronic non-communicable illnesses like diabetes and heart disease kill people living with HIV, not the virus itself, researchers say. They suggest regular screening for chronic diseases and management of risk factors to prevent negative health outcomes. 

In this week's World Wednesday post we look at our International Vice Chair Dr. Ian Sanne's work fighting Ebola in Africa. In addition to being an investigator with the ACTG, Dr. Sanne runs Right to Care in South Africa. Right to Care is looking for applicants willing to work in Sierra Leone for three months to treat people with Ebola. Dr. Sanne says this would be meaningful experience, especially if the disease ever comes to South Africa. #ebola #worldwednesday #africa http://ift.tt/1vZgxQQ

In this week's World Wednesday post we look at our International Vice Chair Dr. Ian Sanne's work fighting Ebola in Africa. In addition to being an investigator with the ACTG, Dr. Sanne runs Right to Care in South Africa. Right to Care is looking for applicants willing to work in Sierra Leone for three months to treat people with Ebola. Dr. Sanne says this would be meaningful experience, especially if the disease ever comes to South Africa.

Dr. Diane Havlir leads our University of San Francisco HIV/AIDS Clinical Research Site. She is also one of the co-founders of the city's Getting to Zero Coalition. The group aims to make San Francisco the first jurisdiction with zero new HIV infections, zero stigma and zero deaths! #hiv #aids #sanfrancisco http://ift.tt/13u4zc8

Dr. Diane Havlir leads our University of San Francisco HIV/AIDS Clinical Research Site. She is also one of the co-founders of the city's Getting to Zero Coalition. The group aims to make San Francisco the first jurisdiction with zero new HIV infections, zero stigma and zero deaths!

Have you ever wondered what inspired your physician to pursue a career caring for people living with HIV and researching new treatments? Watch a video of our Network Chair Dr. Dan Kuritzkes along with Drs. Jonathan Li, Tim Henrich and Athe Tsibris sharing what attracted them to the field. http://ift.tt/1cYAmBG #actg2014 #hiv #aids #research #science #health http://ift.tt/1wA6NAu

Have you ever wondered what inspired your physician to pursue a career caring for people living with HIV and researching new treatments? Watch this video of our Network Chair Dr. Dan Kuritzkes along with Drs. Jonathan Li, Tim Henrich and Athe Tsibris sharing what attracted them to the field.

Dr. Igho Ofotokun grew up in Nigeria. He says watching women living with HIV come to the local clinic seeking treatment so that they could continue caring for their children inspired him to become a doctor and specialize in women's health. #hiv #actg2014 #aids #womenshealth #nigeria http://ift.tt/1wniYQZ

Dr. Igho Ofotokun grew up in Nigeria. He says watching women living with HIV come to the local clinic seeking treatment so that they could continue caring for their children inspired him to become a doctor and specialize in women's health at Emory in Atlanta. Read more about him in our December newsletter!

Dr. Johnstone Kumwenda from our research site in Blantyre, Malawi, is conducting our first study into malaria and HIV. He will test the protease inhibitor class of HIV medications to see if this is a safer and more effective means of curing malaria in people living with HIV. #actg2014 #hiv #aids #malaria #research http://ift.tt/1wgYkTV

Dr. Johnstone Kumwenda from our research site in Blantyre, Malawi, is conducting our first study into malaria and HIV. He will test the protease inhibitor class of HIV medications to see if this is a safer and more effective means of curing malaria in people living with HIV. Read more about his study and where it is enrolling in our December newsletter.

In this week's World Wednesday post, our Dr. Aida Asmelash from our Botswana sites conducted a study investigating why African women taking anti-HIV medications can suppress HIV, but still not see a CD4 cell recovery. She learned that older age and co-infections are factors that influence immune restoration. #actg2014 #aids #hiv #research #worldwednesday http://ift.tt/1yPIvUZ

In this week's World Wednesday post, our Dr. Aida Asmelash from our Botswana sites conducted a study investigating why African women taking anti-HIV medications can suppress HIV, but still not see a CD4 cell recovery. She learned that older age and co-infections are factors that influence immune restoration. Read more in our December newsletter.

When a lifelong friend's husband was diagnosed with HIV, Vicki Bailey was inspired to attend nursing school and specialize in caring for people living with HIV. She's been a research nurse at our Vanderbilt site in Nashville for 14 years. #actg2014 #hiv #aids #nursing #vanderbilt #nashville http://ift.tt/1ywjLlS